VLDLR and neoplasm: The liposome surface was modified with mApoE to increase brain penetration and tumor cell uptake by low-density lipoprotein receptor (LDL-R) targeting (Pawar et al., 2021) and with MSLP to confer an MMP-dependent drug release.